Geographic Atrophy

Latest News

Astellas receives permanent J-code for avacincaptad pegol intravitreal solution for GA
Astellas receives permanent J-code for avacincaptad pegol intravitreal solution for GA

March 26th 2024

Since its U.S. launch in September 2023, more than 40,000 avacincaptad pegol intravitreal solution vials have been distributed to physician practices.

Study shows minocycline has no benefit in slowing geographic atrophy expansion in patients with dry age-related macular degeneration
Study shows minocycline has no benefit in slowing geographic atrophy expansion in patients with dry age-related macular degeneration

March 22nd 2024

Ocugen completes dosing of subjects with geographic atrophy in Phase 1/2 clinical trial of OCU410
Ocugen completes dosing of subjects with geographic atrophy in Phase 1/2 clinical trial of OCU410

March 13th 2024

Reaching consensus on Geographic Atrophy diagnosis and management
Reaching consensus on Geographic Atrophy diagnosis and management

March 4th 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.